IMMUNIC, INC. - Common Stock (IMUX)

Historical Holders from Q2 2019 to Q3 2025

Symbol
IMUX on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
120,284,725
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
42,691,219
Holdings value
$37,637,800
% of all portfolios
0%
Number of holders
61
Number of buys
24
Number of sells
-19
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IMMUNIC, INC. - Common Stock (IMUX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 9.99% +2.3% $8,531,675 +$6,622,427 12,016,444 +3.5% JANUS HENDERSON GROUP PLC 28 Nov 2025
Alyeska Investment Group, L.P. 9.35% -5.5% $9,918,000 +$1,555,199 11,250,000 +18.6% Alyeska Investment Group, L.P. 30 Sep 2025
Nantahala Capital Management, LLC 9.99% $8,826,689 10,634,565 Nantahala Capital Management, LLC 30 Jun 2025
683 Capital Management, LLC 9.9% $8,826,590 10,634,446 683 CAPITAL MANAGEMENT, LLC 02 Aug 2025
Adage Capital Management, L.P. 9.99% +4.2% $8,697,850 +$7,537,012 10,479,337 +6.5% Adage Capital Management, L.P. 30 Jun 2025
BIOTECHNOLOGY VALUE FUND L P 9.99% $8,121,698 9,785,178 BVF PARTNERS L P/IL 30 Jun 2025
Aberdeen Group plc 8.6% $6,842,471 8,243,941 Aberdeen Group plc 30 Jun 2025
Avidity Partners Management LP 4.8% -18.3% $4,143,001 -$807,898 4,699,411 -16.3% Avidity Partners Management LP 30 Sep 2025
VANGUARD GROUP INC 4.35% $4,473,090 3,923,763 The Vanguard Group 31 Dec 2024
Soleus Private Equity Fund III, L.P. 1.6% $1,392,934 1,580,007 Soleus Capital Management, L.P. 30 Sep 2025
RTW INVESTMENTS, LP 1.1% $1,170,509 1,026,762 RTW Investments, LP 31 Mar 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $328,030 -$49,773 372,085 -13.2% Armistice Capital, LLC 30 Sep 2025

Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 42,691,219 $37,637,800 -$6,009,914 $0.8816 61
2025 Q2 50,178,419 $35,007,422 +$6,044,822 $0.6975 55
2025 Q1 40,453,267 $44,092,350 -$10,908,092 $1.09 63
2024 Q4 51,078,929 $51,080,793 -$5,070,929 $1 65
2024 Q3 55,990,706 $92,402,857 +$4,082,986 $1.65 61
2024 Q2 55,825,550 $62,078,863 -$1,856,872 $1.11 57
2024 Q1 57,356,707 $75,746,429 +$55,567,381 $1.32 60
2023 Q4 15,140,220 $22,708,217 -$4,865,374 $1.5 49
2023 Q3 18,373,010 $27,006,486 -$3,552,617 $1.47 53
2023 Q2 20,191,368 $50,673,312 -$8,732,751 $2.51 62
2023 Q1 24,789,103 $36,932,167 +$1,129,629 $1.49 57
2022 Q4 24,354,230 $34,040,740 +$5,454,473 $1.4 59
2022 Q3 17,440,399 $55,106,794 -$3,092,179 $3.16 62
2022 Q2 18,260,665 $63,350,669 -$15,186,048 $3.47 65
2022 Q1 17,606,263 $198,949,802 +$44,387,028 $11.3 78
2021 Q4 13,709,674 $131,117,717 +$7,603,275 $9.57 66
2021 Q3 12,872,467 $113,976,993 +$30,193,655 $8.85 66
2021 Q2 9,434,902 $115,673,222 -$1,395,354 $12.26 56
2021 Q1 9,300,714 $148,252,917 -$6,173,953 $15.94 60
2020 Q4 9,727,941 $148,744,642 +$11,593,540 $15.29 66
2020 Q3 8,546,270 $158,699,665 +$86,090,223 $18.57 64
2020 Q2 4,206,160 $51,019,563 +$24,949,305 $12.12 47
2020 Q1 2,155,699 $13,039,030 +$104,044 $6.01 15
2019 Q4 2,138,466 $20,744,048 +$6,193,891 $9.7 14
2019 Q3 1,499,379 $14,993,920 -$480,203 $10 18
2019 Q2 1,536,778 $17,625,202 +$17,623,000 $11.46 20